Copyright
©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 21, 2007; 13(15): 2187-2192
Published online Apr 21, 2007. doi: 10.3748/wjg.v13.i15.2187
Published online Apr 21, 2007. doi: 10.3748/wjg.v13.i15.2187
Table 3 Interactions between -2518 CCL2 G and 190 CCR2 A mutations
| Chronic hepatitis | F0-F2 | F3-F4 | SR | NSR | Healthy controls | ||
| n = 284 (%) | n = 202 (%) | n = 82 (%) | n =101 (%) | n =98 (%) | n = 193 (%) | ||
| CCL2G | CCR2A | 31 (10.9) | 22 (10.9) | 9 (11.0) | 10 (9.9) | 11 (11.2) | 13 (6.7) |
| CCL2G | CCR2G | 85 (29.9) | 57 (28.2) | 28 (34.1) | 27 (26.7) | 32 (32.6) | 61 (31.6) |
| CCL2A | CCR2A | 48 (16.9) | 34 (16.8) | 14 (17.1) | 19 (18.8) | 13 (13.3) | 24 (12.4) |
| CCL2A | CCR2G | 120 (42.2) | 89 (44.1) | 31 (37.8) | 45 (44.5) | 42 (42.8) | 95 (49.2) |
- Citation: Montes-Cano M, García-Lozano J, Aguilar-Reina J, Romero-Gómez M, Barroso N, Núñez-Roldán A, González-Escribano M. CCL2-2518 A/G and CCR2 190 A/G do not influence the outcome of hepatitis C virus infection in the Spanish population. World J Gastroenterol 2007; 13(15): 2187-2192
- URL: https://www.wjgnet.com/1007-9327/full/v13/i15/2187.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i15.2187